Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Feigert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|September 15, 1988
Case 11-1988J M Feigert, R L Nachman
The Journal of the American Board of Family Practice|September 1, 1996
Rapidly progressive prostate cancer in the primary care settingS H Woolf, R Mugol, J M Feigert, et al.
Annals of Internal Medicine|September 1, 1990
Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndromeJ M Feigert, D L Sweet, M Coleman, et al.
Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|September 15, 1988
Case 11-1988J M Feigert, R L Nachman
The Journal of the American Board of Family Practice|September 1, 1996
Rapidly progressive prostate cancer in the primary care settingS H Woolf, R Mugol, J M Feigert, et al.
Annals of Internal Medicine|September 1, 1990
Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndromeJ M Feigert, D L Sweet, M Coleman, et al.
Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.
Pageof 1